Neo-Synephrine Maximum
- Product NDC
- 0225-0810
- 11-digit product format
- 002250810
- Labeler code
- 0225
- Product ID
- 0225-0810_0a49488a-841e-7937-e063-6294a90aeac8
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- PHENYLEPHRINE HYDROCHLORIDE
- Dosage form
- SPRAY
- Route
- NASAL
- Labeler
- BF ASCHER AND CO INC
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2020-07-01
- Substance
- PHENYLEPHRINE HYDROCHLORIDE
- Active strength
- 1 g/100mL
- Pharmacologic classes
- Adrenergic alpha1-Agonists [MoA], alpha-1 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Neo-Synephrine Maximum
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PHENYLEPHRINE HYDROCHLORIDE | 1 g/100mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 04JA59TNSJ |
| Rxcui | 1087043, 1234569 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0225-0810-47 | Neo-Synephrine Maximum | 15 mL in 1 BOTTLE, SPRAY | SPRAY | 15 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0225-0810 | NEO-SYNEPHRINE MAXIMUM (PHENYLEPHRINE HYDROCHLORIDE) SPRAY [BF ASCHER AND CO INC] | 3 | Current NDC, Legacy NDC, 1 package rows | 20231117_ab8682a4-1f66-6709-e053-2995a90a8b4a.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0225-0810-47 | 00225081047 | 15 mL in 1 BOTTLE, SPRAY (0225-0810-47) | 15 ml | 2020-07-01 | 0000-00-00 | No | No | Current |